Case Report: A Pancreatic Ductal Adenocarcinoma Patient With Concurrent Targetable Somatic Novel KANK1-ALK, UPP2-NTRK3 Fusion, and Pathogenetic Germline BRCA Mutation

Case Report: A Pancreatic Ductal Adenocarcinoma Patient With Concurrent Targetable Somatic Novel KANK1-ALK, UPP2-NTRK3 Fusion, and Pathogenetic Germline BRCA Mutation

Pancreatic ductal adenocarcinoma (PDAC) is presently one of the cancers with the worst survival rates. The current treatment options for PDAC are relatively scarce due to insufficient understanding of molecular characteristics and subtypes of PDAC. Based on next-generation sequencing (NGS), we first...

Full description

Bibliographic Details
Main Authors: Fan Meng, Le Lu, Yuan Tan, Qianqian Duan, Hongwei Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Oncology
Subjects:
PDAC
KANK1-ALK
UPP2-NTRK3
pathogenetic BRCA1 mutation
next-generation sequencing
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.757965/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.757965/full

Similar Items